Targeting CVD in diabetes: Novel strategies to tackle the risk10' education - Apr. 11, 2019 - EuroPrevent 2019 - John Deanfield, MD – London, United Kingdom
EuroPrevent 2019 Prof. Deanfield reflects on a new era in CVD prevention for patients with diabetes. He discusses how can we prevent diabetes and manage diabetes exposure in the general population.
Video navigation menu
- Diabetes: new era in CVD prevention 01:53
- Use of GLP-1RA and SGLT2-i in clincial practice 04:02
- Prevention of diabetes in general population 06:59
- Managing diabetes exposure to reduce the risk of future diabetes 08:40
This lecture by prof. John Deanfield was part of a CME accredited symposium "The preventive challenge in diabetes & CVD - A multidisciplinary approach"
Prof. Deanfield - Professor of Cardiology at University College London (UCL) and Consultant Cardiologist at the Barts Heart Centre (BHC) London UK. He is the Director of the National Centre for Cardiovascular disease Prevention and Outcomes (NCCPO) at UCL, and Chairman of National Institute for Cardiovascular (CV) Outcomes Research (NICOR)
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk.